Veitch, S., Njock, M.S., Chandy, M., Siraj, M.A., Chi, L., Mak, H., Yu, K., Rathnakumar, K., Perez-Romero, C.A., Chen, Z., Alibhai, F.J., Gustafson, D., Raju, S., Wu, R., Zarrin Khat, D., Wang, Y., Caballero, A., Meagher, P., Lau, E., Pepic, L., Cheng, H.S., Galant, N.J., Howe, K.L., Li, R.K., Connelly, K.A., Husain, M., Delgado-Olguin, P., Fish, J.E. (2022). MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes. Cardiovascular Diabetology, 21(1), art. no. 31.
https://doi.org/10.1186/s12933....